Partners-PhytoHealth Corporation

By integrating resources in research, development, manufacturing, and distribution, PhytoHealth has established a clear and comprehensive cooperation model.

Out-Licensing

We have a research and development product line of botanical new drugs, new dosage forms, and new ingredients. The products and projects that out-licensed are including: PG2® injection, Oraphine®, PHN031, PHN033

Products ready for out-licensing

PG2® Injection

Oraphine®

Projects ready for out-licensing

PHN031

Completed Phase IIa clinical trial approved by the US FDA

PHN033

Completed Phase IIa clinical trial approved by the US FDA

Co-Development and Distribution

PhytoHealth is committed to the development of new drugs; we have the relevant skill sets and many years of experience in the fields of sales, marketing, product development, clinical development, and laws and regulations. We are interested in any potential opportunity of co-development and distribution of new drugs, so please don’t hesitate to bring up your proposal to us for our review and assessment.